Showing results (2141-2150 of 2,869) with videos related to
Sort By:
Pageof 287
Japanese Heart Journal|May 1, 1992
Safety and efficacy of a modified catheter-mediated ablation of accessory pathwaysS A Chen, W P Tsang, D C Wang, et al.Virology|December 10, 2013
Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancerAlyce A Chen, Daniëlle A M Heideman, Debby Boon, et al.Transplantation|June 8, 2022
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and OutcomesGermaine Wong, Matthew Rowlandson, Dharshana Sabanayagam, et al.American Heart Journal|August 1, 1992
Catheter ablation of accessory atrioventricular pathways in 114 symptomatic patients with Wolff-Parkinson-White syndrome--a comparative study of direct-current and radiofrequency ablationS A Chen, W P Tsang, C P Hsia, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
Deconfounded Dimension Reduction via Partial EmbeddingsAndrew A Chen, Kelly Clark, Blake Dewey, et al.JAMA Internal Medicine|April 21, 2025
Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical TrialKara M Magane, Kimberly A Dukes, Sarah Fielman, et al.Journal of Fungi (Basel, Switzerland)|September 22, 2022
Whole Genome Sequencing Shows Genetic Diversity, as Well as Clonal Complex and Gene Polymorphisms Associated with Fluconazole Non-Susceptible Isolates of Candida tropicalisCaitlin Keighley, Mailie Gall, Sebastiaan J van Hal, et al.Transplantation Proceedings|February 5, 2013
Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patientsH-Y Chang, L-W Lo, A-N Feng, et al.The Journal of Antimicrobial Chemotherapy|March 31, 2026
Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy studyJohan Maertens, Sharon C A Chen, George R Thompson, et al.AIDS and Behavior|October 16, 2012
Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in womenAlexandra M Minnis, Sharavi Gandham, Barbra A Richardson, et al.Pageof 287